A Multicenter Validation of a Fully Automated Chemiluminescence Immunoassay for Plasma Elafin in Psoriasis Diagnosis and Severity Assessment
Advanced Science · 2025
DOI: 10.1002/advs.202511535 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Advanced Science, 2025. Verfasst von Jingkun Yi und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing …. Hauptthemen laut MEDLINE: Psoriasis, Luminescent Measurements, Elafin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Guangdong Province Science and Technology Planning Project, Guangdong-PHOENIX Center Joint Lab on Chinese Medicine, National Key R&D Program of China.
Abstract (Originalsprache)
Psoriasis diagnosis and severity assessment rely on subjective skin evaluations. Elafin is a promising biomarker, yet no high‐throughput clinical assay exists. A chemiluminescence immunoassay (CLIA) reagent kit for plasma Elafin has been developed and validated using automated analyzers to enable rapid diagnosis, objective severity stratification, and longitudinal monitoring. Analytical performance is rigorously assessed, including the limit of blank (LoB) (0.069 ng mL −1 ), limit of detection (LoD) (0.099 ng mL −1 ), limit of quantification (LoQ) (0.8 ng mL −1 ), linearity (0.8–200 ng mL −1 ), precision, recovery, reproducibility, and interference resistance. Plasma Elafin is quantified in 731 participants from five hospitals: 112 healthy controls, 466 psoriasis patients (mild = 164, moderate = 158, severe = 144), and 153 disease controls. The assay achieves 89% diagnostic accuracy with an area under the receiver operating characteristic curve (AUC) of 0.94 for psoriasis. It effectively distinguishes disease severity (AUC 0.68 mild vs moderate; 0.77 moderate vs severe), and Elafin levels correlated with treatment duration in moderate (R = 0.51) and severe (R = 0.41) cases. This CLIA reagent kit demonstrates excellent analytical and clinical performance, supporting automated, high‐throughput Elafin detection as a reliable tool for diagnosing and managing moderate‐to‐severe psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China.
- Department of Biomedical Informatics, State Key Laboratory of Vascular Homeostasis and Remodeling, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
- Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, China.
- The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510000, China.
- Chinese Medicine Guangdong Laboratory, Hengqin, Guangdong, 519000, China.
- State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, 510120, China.
ORCID-Profile: Jingkun Yi, Xiaobo Yu
Förderung
- Guangdong Province Science and Technology Planning Project
- Guangdong-PHOENIX Center Joint Lab on Chinese Medicine
- National Key R&D Program of China
- Beijing Municipal International Cooperation and Exchange Project
- Beijing Municipal Natural Science Foundation
- PHOENIX Center and Guangdong Provincial Hospital of Chinese Medicine
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Yi, J., Xu, M., Han, L., Dong, Z., Liu, R., Zhang, X., Hu, D., Lu, C., & Yu, X. (2025). A Multicenter Validation of a Fully Automated Chemiluminescence Immunoassay for Plasma Elafin in Psoriasis Diagnosis and Severity Assessment. Advanced Science. https://doi.org/10.1002/advs.202511535
Vancouver
Yi J, Xu M, Han L, Dong Z, Liu R, Zhang X, et al. A Multicenter Validation of a Fully Automated Chemiluminescence Immunoassay for Plasma Elafin in Psoriasis Diagnosis and Severity Assessment. Advanced Science. 2025. doi:10.1002/advs.202511535
BibTeX
@article{Yi2025,
author = {Yi, Jingkun and Xu, Meng and Han, Ling and Dong, Zhining and Liu, Ruimin and Zhang, Xiaomei and Hu, Di and Lu, Chuanjian and Yu, Xiaobo},
title = {A Multicenter Validation of a Fully Automated Chemiluminescence Immunoassay for Plasma Elafin in Psoriasis Diagnosis and Severity Assessment},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202511535}
}
EUVIMED